RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Washington D.C., DC · +50 more sites
Ulcerative Colitis clinical trials in Washington D.C., DC
4 recruiting ulcerative colitis studies with a site in Washington D.C., DC.
All trials in Washington D.C., DC · All Ulcerative Colitis trials
RecruitingPhase 2 / Phase 3NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Sponsor: Bristol-Myers Squibb
Washington D.C., DC · +35 more sites
RecruitingNot applicableNCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Sponsor: Mayo Clinic
Washington D.C., DC · +23 more sites
RecruitingPhase not listedNCT06065228
Therapeutic Endpoint in Pediatric IBD Conditions
Sponsor: Children's National Research Institute
Washington D.C., DC
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.